After Lecanemab, a monoclonal antibody medication for Alzheime's, Eli Lilly and Co. too reported promising phase 3 trial results of its drug, Donanenab, for the disease.
While lecanemab saw less decline in cognition and function of patients, the drug is effective only at a very early stage -- closer to the onset of the disease.
Scientists from University of Wisconsin-Madison, also identified the selective serotonin reuptake inhibitor antidepressant Fluoxetine as being helpful, especially when combined with exercise.
Study by Northwestern University team published in Journal of Neuroscience. SuperAgers have larger neurons than those with early-stage Alzheimer’s & people 2-3 decades younger, it says.
US FDA has approved Aduhelm drug, which proposes to work by chipping away at protein deposits in the brain that cause memory loss and other symptoms of Alzheimer’s.
The new drug, which Biogen developed with Japan's Eisai Co., did not reverse mental decline, but only slowed it in one study. The drug is given as an infusion every four weeks.
The findings were revealed at the Alzheimer’s Association International Conference and the American Heart Association’s Basic Cardiovascular Sciences 2020 Scientific Sessions.
Lack of sleep inflicts big costs on the economy. Several large organisations – Google included – have sleep pods in their offices for restorative naps.
Finance ministry says the proposed revamp will focus on structural reforms, rate rationalisation & ease of living, & will be deliberated upon in the coming weeks.
The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS